ES2667346T3 - Estrategias de secuenciación de región genómica 3-D de interés - Google Patents

Estrategias de secuenciación de región genómica 3-D de interés Download PDF

Info

Publication number: ES2667346T3
Authority: ES; Spain
Prior art keywords: dna; fragments; interest; sequence; genomic region
Prior art date: 2010-07-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES11736190.7T

Other languages

English (en)

Spanish (es)

Other versions

ES2667346T9 (es

Inventor

Max Jan Van Min

Wouter Leonard De Laat

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Cergentis BV

Original Assignee

Cergentis BV

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-07-09

Filing date

2011-07-08

Publication date

2018-05-10

2011-07-08 Application filed by Cergentis BV filed Critical Cergentis BV

2018-05-10 Application granted granted Critical

2018-05-10 Publication of ES2667346T3 publication Critical patent/ES2667346T3/es

2018-06-11 Publication of ES2667346T9 publication Critical patent/ES2667346T9/es

Status Active legal-status Critical Current

2031-07-08 Anticipated expiration legal-status Critical

Links

238000011451 sequencing strategy Methods 0.000 title description 3
239000012634 fragment Substances 0.000 claims abstract description 340
125000003729 nucleotide group Chemical group 0.000 claims abstract description 121
239000002773 nucleotide Substances 0.000 claims abstract description 119
238000000034 method Methods 0.000 claims abstract description 96
238000004132 cross linking Methods 0.000 claims abstract description 49
108020004414 DNA Proteins 0.000 claims description 391
239000000523 sample Substances 0.000 claims description 80
238000013467 fragmentation Methods 0.000 claims description 57
238000006062 fragmentation reaction Methods 0.000 claims description 57
238000012163 sequencing technique Methods 0.000 claims description 50
108091008146 restriction endonucleases Proteins 0.000 claims description 44
230000003321 amplification Effects 0.000 claims description 33
238000003199 nucleic acid amplification method Methods 0.000 claims description 33
108091028043 Nucleic acid sequence Proteins 0.000 claims description 27
230000002255 enzymatic effect Effects 0.000 claims description 12
238000000527 sonication Methods 0.000 claims description 11
FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 8
GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 claims description 7
102000004190 Enzymes Human genes 0.000 claims description 6
108090000790 Enzymes Proteins 0.000 claims description 6
230000008439 repair process Effects 0.000 claims description 6
206010010356 Congenital anomaly Diseases 0.000 claims description 5
230000008878 coupling Effects 0.000 claims description 4
238000010168 coupling process Methods 0.000 claims description 4
238000005859 coupling reaction Methods 0.000 claims description 4
238000000605 extraction Methods 0.000 claims description 4
238000001502 gel electrophoresis Methods 0.000 claims description 4
238000004587 chromatography analysis Methods 0.000 claims description 3
238000000432 density-gradient centrifugation Methods 0.000 claims description 2
239000013615 primer Substances 0.000 description 63
230000035772 mutation Effects 0.000 description 54
210000004027 cell Anatomy 0.000 description 48
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 30
238000003752 polymerase chain reaction Methods 0.000 description 26
108090000623 proteins and genes Proteins 0.000 description 21
108700028369 Alleles Proteins 0.000 description 18
239000000047 product Substances 0.000 description 17
102000004169 proteins and genes Human genes 0.000 description 13
238000006243 chemical reaction Methods 0.000 description 11
210000000349 chromosome Anatomy 0.000 description 11
230000000875 corresponding effect Effects 0.000 description 10
101150072950 BRCA1 gene Proteins 0.000 description 9
108091034117 Oligonucleotide Proteins 0.000 description 9
238000005516 engineering process Methods 0.000 description 9
230000003993 interaction Effects 0.000 description 9
210000001519 tissue Anatomy 0.000 description 9
ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 8
108700040618 BRCA1 Genes Proteins 0.000 description 7
150000007523 nucleic acids Chemical class 0.000 description 7
238000011282 treatment Methods 0.000 description 7
YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 6
102000053602 DNA Human genes 0.000 description 6
206010028980 Neoplasm Diseases 0.000 description 6
201000011510 cancer Diseases 0.000 description 6
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 6
UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 6
238000009396 hybridization Methods 0.000 description 6
102000039446 nucleic acids Human genes 0.000 description 6
108020004707 nucleic acids Proteins 0.000 description 6
239000007787 solid Substances 0.000 description 6
LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 5
238000004458 analytical method Methods 0.000 description 5
238000013459 approach Methods 0.000 description 5
238000012217 deletion Methods 0.000 description 5
230000037430 deletion Effects 0.000 description 5
201000010099 disease Diseases 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
238000003780 insertion Methods 0.000 description 5
230000037431 insertion Effects 0.000 description 5
238000001574 biopsy Methods 0.000 description 4
230000029087 digestion Effects 0.000 description 4
238000012545 processing Methods 0.000 description 4
RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 4
230000005945 translocation Effects 0.000 description 4
229940035893 uracil Drugs 0.000 description 4
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
229930024421 Adenine Natural products 0.000 description 3
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
108091093088 Amplicon Proteins 0.000 description 3
239000003155 DNA primer Substances 0.000 description 3
238000012408 PCR amplification Methods 0.000 description 3
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
229960000643 adenine Drugs 0.000 description 3
229960002685 biotin Drugs 0.000 description 3
235000020958 biotin Nutrition 0.000 description 3
239000011616 biotin Substances 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
230000002759 chromosomal effect Effects 0.000 description 3
230000000295 complement effect Effects 0.000 description 3
210000001840 diploid cell Anatomy 0.000 description 3
210000004392 genitalia Anatomy 0.000 description 3
239000003550 marker Substances 0.000 description 3
230000008569 process Effects 0.000 description 3
238000000926 separation method Methods 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
206010006187 Breast cancer Diseases 0.000 description 2
208000026310 Breast neoplasm Diseases 0.000 description 2
108010077544 Chromatin Proteins 0.000 description 2
239000004971 Cross linker Substances 0.000 description 2
102000012410 DNA Ligases Human genes 0.000 description 2
108010061982 DNA Ligases Proteins 0.000 description 2
238000001712 DNA sequencing Methods 0.000 description 2
108060002716 Exonuclease Proteins 0.000 description 2
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 2
102000005891 Pancreatic ribonuclease Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
239000004365 Protease Substances 0.000 description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
241000700605 Viruses Species 0.000 description 2
230000003044 adaptive effect Effects 0.000 description 2
238000003556 assay Methods 0.000 description 2
210000003483 chromatin Anatomy 0.000 description 2
238000004590 computer program Methods 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
230000002596 correlated effect Effects 0.000 description 2
239000003431 cross linking reagent Substances 0.000 description 2
229940104302 cytosine Drugs 0.000 description 2
238000001514 detection method Methods 0.000 description 2
238000011161 development Methods 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
102000013165 exonuclease Human genes 0.000 description 2
238000011049 filling Methods 0.000 description 2
230000007614 genetic variation Effects 0.000 description 2
238000012165 high-throughput sequencing Methods 0.000 description 2
230000003426 interchromosomal effect Effects 0.000 description 2
WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
230000011987 methylation Effects 0.000 description 2
238000007069 methylation reaction Methods 0.000 description 2
239000000203 mixture Substances 0.000 description 2
238000007481 next generation sequencing Methods 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
102000040430 polynucleotide Human genes 0.000 description 2
108091033319 polynucleotide Proteins 0.000 description 2
239000002157 polynucleotide Substances 0.000 description 2
239000002244 precipitate Substances 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
239000002987 primer (paints) Substances 0.000 description 2
238000000746 purification Methods 0.000 description 2
238000003908 quality control method Methods 0.000 description 2
239000013074 reference sample Substances 0.000 description 2
239000013049 sediment Substances 0.000 description 2
239000000243 solution Substances 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
229940113082 thymine Drugs 0.000 description 2
LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical group CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 description 1
102000036365 BRCA1 Human genes 0.000 description 1
108700010154 BRCA2 Genes Proteins 0.000 description 1
208000035143 Bacterial infection Diseases 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
230000009946 DNA mutation Effects 0.000 description 1
230000007023 DNA restriction-modification system Effects 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108091027305 Heteroduplex Proteins 0.000 description 1
108010033040 Histones Proteins 0.000 description 1
102000006947 Histones Human genes 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000836075 Homo sapiens Serpin B9 Proteins 0.000 description 1
101000661807 Homo sapiens Suppressor of tumorigenicity 14 protein Proteins 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
102100030569 Nuclear receptor corepressor 2 Human genes 0.000 description 1
101710153660 Nuclear receptor corepressor 2 Proteins 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
108091093037 Peptide nucleic acid Proteins 0.000 description 1
CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
108091028664 Ribonucleotide Proteins 0.000 description 1
239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
102100025517 Serpin B9 Human genes 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
101100439974 Streptococcus pneumoniae serotype 4 (strain ATCC BAA-334 / TIGR4) clpE gene Proteins 0.000 description 1
208000036142 Viral infection Diseases 0.000 description 1
YTAHJIFKAKIKAV-XNMGPUDCSA-N [(1R)-3-morpholin-4-yl-1-phenylpropyl] N-[(3S)-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl]carbamate Chemical compound O=C1[C@H](N=C(C2=C(N1)C=CC=C2)C1=CC=CC=C1)NC(O[C@H](CCN1CCOCC1)C1=CC=CC=C1)=O YTAHJIFKAKIKAV-XNMGPUDCSA-N 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
208000022362 bacterial infectious disease Diseases 0.000 description 1
239000011324 bead Substances 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
230000006037 cell lysis Effects 0.000 description 1
210000003855 cell nucleus Anatomy 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
238000010276 construction Methods 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
238000004163 cytometry Methods 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
238000013461 design Methods 0.000 description 1
229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
238000006911 enzymatic reaction Methods 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
230000014509 gene expression Effects 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
210000005260 human cell Anatomy 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
239000012139 lysis buffer Substances 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
238000002493 microarray Methods 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
210000004940 nucleus Anatomy 0.000 description 1
238000011275 oncology therapy Methods 0.000 description 1
238000005457 optimization Methods 0.000 description 1
230000008520 organization Effects 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
230000000737 periodic effect Effects 0.000 description 1
238000002205 phenol-chloroform extraction Methods 0.000 description 1
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
239000010452 phosphate Substances 0.000 description 1
238000004393 prognosis Methods 0.000 description 1
239000002336 ribonucleotide Substances 0.000 description 1
125000002652 ribonucleotide group Chemical group 0.000 description 1
238000005096 rolling process Methods 0.000 description 1
238000007480 sanger sequencing Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
238000012216 screening Methods 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
238000010200 validation analysis Methods 0.000 description 1
230000009385 viral infection Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
- C12Q1/6855—Ligating adaptors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/30—Phosphoric diester hydrolysing, i.e. nuclease
- C12Q2521/301—Endonuclease
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/50—Other enzymatic activities
- C12Q2521/501—Ligase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/101—Crosslinking agents, e.g. psoralen
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2523/00—Reactions characterised by treatment of reaction samples
- C12Q2523/10—Characterised by chemical treatment
- C12Q2523/107—Chemical cleaving agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/30—Oligonucleotides characterised by their secondary structure
- C12Q2525/307—Circular oligonucleotides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers

Landscapes

Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
General Health & Medical Sciences (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Immunology (AREA)
Analytical Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Plant Pathology (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
General Chemical & Material Sciences (AREA)

ES11736190.7T 2010-07-09 2011-07-08 Estrategias de secuenciación de región genómica 3-D de interés Active ES2667346T3 (es)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US36277810P	2010-07-09	2010-07-09
US362778P		2010-07-09
PCT/NL2011/050504 WO2012005595A2 (fr)	2010-07-09	2011-07-08	Stratégies de séquençage de la région génomique d'intérêt v3-d

Publications (2)

Publication Number	Publication Date
ES2667346T3 true ES2667346T3 (es)	2018-05-10
ES2667346T9 ES2667346T9 (es)	2018-06-11

Family

ID=44629077

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
ES11736190.7T Active ES2667346T3 (es)	2010-07-09	2011-07-08	Estrategias de secuenciación de región genómica 3-D de interés
ES18163123T Active ES2916339T3 (es)	2010-07-09	2011-07-08	Estrategias de secuenciación de región genómica de interés 3D

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
ES18163123T Active ES2916339T3 (es)	2010-07-09	2011-07-08	Estrategias de secuenciación de región genómica de interés 3D

Country Status (26)

Country	Link
US (2)	US12006538B2 (fr)
EP (3)	EP2591125B1 (fr)
JP (1)	JP5977234B2 (fr)
KR (1)	KR101862756B1 (fr)
CN (1)	CN103180459B (fr)
AU (1)	AU2011274642B2 (fr)
BR (1)	BR112013000552B8 (fr)
CA (1)	CA2804450C (fr)
CY (1)	CY1121702T1 (fr)
DK (2)	DK3360975T3 (fr)
ES (2)	ES2667346T3 (fr)
HR (1)	HRP20180593T1 (fr)
HU (1)	HUE037359T2 (fr)
IL (2)	IL224127B (fr)
LT (1)	LT2591125T (fr)
NO (1)	NO2591125T3 (fr)
NZ (1)	NZ606228A (fr)
PL (2)	PL2591125T3 (fr)
PT (2)	PT3360975T (fr)
RS (1)	RS57295B1 (fr)
RU (1)	RU2603082C2 (fr)
SG (1)	SG186954A1 (fr)
SI (1)	SI2591125T1 (fr)
SM (1)	SMT201800213T1 (fr)
WO (1)	WO2012005595A2 (fr)
ZA (1)	ZA201300375B (fr)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2760439A1 (fr)	2009-04-30	2010-11-04	Good Start Genetics, Inc.	Procedes et compositions d'evaluation de marqueurs genetiques
US12129514B2 (en)	2009-04-30	2024-10-29	Molecular Loop Biosolutions, Llc	Methods and compositions for evaluating genetic markers
HRP20180593T1 (hr)	2010-07-09	2018-07-27	Cergentis B.V.	Strategije 3-d sekvenciranja genomskog područja od interesa
US9163281B2 (en)	2010-12-23	2015-10-20	Good Start Genetics, Inc.	Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction
EP2753715A4 (fr)	2011-09-09	2015-05-20	Univ Leland Stanford Junior	Procédés permettant d'obtenir une séquence
EP2766498B1 (fr)	2011-10-14	2019-06-19	President and Fellows of Harvard College	Séquençage par assemblage structurel
US9228233B2 (en)	2011-10-17	2016-01-05	Good Start Genetics, Inc.	Analysis methods
EP4249605B1 (fr)	2011-12-22	2024-08-28	President And Fellows Of Harvard College	Procédés de détection d'analyte
ES2991004T3 (es)	2011-12-22	2024-12-02	Harvard College	Métodos para la detección de analitos
US8209130B1 (en)	2012-04-04	2012-06-26	Good Start Genetics, Inc.	Sequence assembly
US10227635B2 (en)	2012-04-16	2019-03-12	Molecular Loop Biosolutions, Llc	Capture reactions
WO2013184754A2 (fr)	2012-06-05	2013-12-12	President And Fellows Of Harvard College	Séquençage spatial d'acides nucléiques à l'aide de sondes d'origami d'adn
US9411930B2 (en)	2013-02-01	2016-08-09	The Regents Of The University Of California	Methods for genome assembly and haplotype phasing
CN108624668B (zh)	2013-02-01	2022-12-02	加利福尼亚大学董事会	用于基因组组装及单体型定相的方法
WO2014129894A1 (fr) *	2013-02-19	2014-08-28	Cergentis B.V.	Stratégies de séquençage pour régions génomiques d'intérêt
US10138509B2 (en)	2013-03-12	2018-11-27	President And Fellows Of Harvard College	Method for generating a three-dimensional nucleic acid containing matrix
US8778609B1 (en)	2013-03-14	2014-07-15	Good Start Genetics, Inc.	Methods for analyzing nucleic acids
US11618923B2 (en)	2013-03-15	2023-04-04	The Broad Institute, Inc.	Methods of determining multiple interactions between nucleic acids in a cell
EP2984182B1 (fr)	2013-04-11	2019-12-11	Sahlén, Pelin	Capture de conformation de chromosome ciblé
MY197877A (en)	2013-06-04	2023-07-22	Harvard College	Rna-guided transcriptional regulation
EP3022320B2 (fr)	2013-07-19	2024-09-25	Ludwig Institute for Cancer Research Ltd	Reconstruction d'haplotype ciblée et au niveau du génome intégral
GB2517936B (en) *	2013-09-05	2016-10-19	Babraham Inst	Chromosome conformation capture method including selection and enrichment steps
WO2015048595A1 (fr) *	2013-09-27	2015-04-02	Jay Shendure	Procédés et systèmes d'échafaudage à grande échelle d'assemblages de génomes
US10851414B2 (en)	2013-10-18	2020-12-01	Good Start Genetics, Inc.	Methods for determining carrier status
GB201320351D0 (en) *	2013-11-18	2014-01-01	Erasmus Universiteit Medisch Ct	Method
WO2015175530A1 (fr)	2014-05-12	2015-11-19	Gore Athurva	Procédés pour la détection d'aneuploïdie
EP2960818A1 (fr) *	2014-06-24	2015-12-30	Institut Pasteur	Procédé, dispositif et programme informatique permettant d'assembler des pièces de chromosomes à partir d'un ou de plusieurs organismes
US10179932B2 (en)	2014-07-11	2019-01-15	President And Fellows Of Harvard College	Methods for high-throughput labelling and detection of biological features in situ using microscopy
WO2016019360A1 (fr)	2014-08-01	2016-02-04	Dovetail Genomics Llc	Marquage d'acides nucléiques pour l'assemblage de séquences
US20160048608A1 (en)	2014-08-15	2016-02-18	Good Start Genetics, Inc.	Systems and methods for genetic analysis
US11408024B2 (en)	2014-09-10	2022-08-09	Molecular Loop Biosciences, Inc.	Methods for selectively suppressing non-target sequences
WO2016048829A1 (fr)	2014-09-24	2016-03-31	Good Start Genetics, Inc.	Commande de procédé pour accroître la robustesse de tests génétiques
WO2016089920A1 (fr)	2014-12-01	2016-06-09	The Broad Institute, Inc.	Procédé de détermination in situ de proximité d'acide nucléique
US10066259B2 (en)	2015-01-06	2018-09-04	Good Start Genetics, Inc.	Screening for structural variants
JP6777966B2 (ja)	2015-02-17	2020-10-28	ダブテイルゲノミクスエルエルシー	核酸配列アセンブリ
GB2554572B (en)	2015-03-26	2021-06-23	Dovetail Genomics Llc	Physical linkage preservation in DNA storage
US10395759B2 (en) *	2015-05-18	2019-08-27	Regeneron Pharmaceuticals, Inc.	Methods and systems for copy number variant detection
WO2017004612A1 (fr)	2015-07-02	2017-01-05	Arima Genomics, Inc.	Déconvolution moléculaire précise de mélanges échantillons
US20180282799A1 (en) *	2015-10-05	2018-10-04	Koninklijke Nederlandse Akademie Van Wetenschappen	Targeted locus amplification using cloning strategies
JP7300831B2 (ja)	2015-10-19	2023-06-30	ダブテイルゲノミクスエルエルシー	ゲノムアセンブリ、ハプロタイプフェージング、および標的に依存しない核酸検出のための方法
EP3366818B1 (fr) *	2015-10-19	2021-04-14	Zhejiang Annoroad Bio-Technology Co., Ltd.	Procédé de construction d'une bibliothèque hi-c à cellules uniques de haute résolution présentant un lot d'informations
GB201518843D0 (en)	2015-10-23	2015-12-09	Isis Innovation	Method of analysing DNA sequences
EP3371329A4 (fr)	2015-11-03	2019-06-19	President and Fellows of Harvard College	Procédé et appareil pour imagerie volumétrique d'une matrice tridimensionnelle contenant des acides nucléiques
ES2926495T3 (es)	2015-12-04	2022-10-26	10X Genomics Inc	Métodos y composiciones para el análisis de ácidos nucleicos
KR102744506B1 (ko) *	2016-02-23	2024-12-18	더브테일 제노믹스 엘엘씨	게놈 어셈블리를 위한 페이징된 판독 세트의 생성 및 반수체형 페이징
CN109415761B (zh)	2016-04-25	2022-09-20	哈佛学院董事及会员团体	用于原位分子检测的杂交链反应方法
GB201608000D0 (en) *	2016-05-06	2016-06-22	Oxford Biodynamics Ltd	Chromosome detection
CN105839196B (zh) *	2016-05-11	2018-04-17	北京百迈客生物科技有限公司	一种真核生物DNA的Hi‑C高通量测序建库方法
SG11201810088SA (en)	2016-05-13	2018-12-28	Dovetail Genomics Llc	Recovering long-range linkage information from preserved samples
KR101915701B1 (ko)	2016-06-16	2018-11-07	한국한의학연구원	돌연변이 발생률의 측정 방법
CN109983125B (zh)	2016-08-31	2024-06-04	哈佛学院董事及会员团体	生成用于通过荧光原位测序检测的核酸序列文库的方法
JP7057348B2 (ja)	2016-08-31	2022-04-19	プレジデントアンドフェローズオブハーバードカレッジ	蛍光ｉｎｓｉｔｕ配列決定を用いた単一アッセイに生体分子の検出を組み合わせる方法
KR102481242B1 (ko) *	2016-12-01	2022-12-23	옥스포드 바이오다이나믹스 피엘씨	암 진단에서 후생적 염색체 상호 작용의 적용
EP3448396A4 (fr)	2017-04-14	2020-01-22	President and Fellows of Harvard College	Procédés de génération d'un réseau de microfilaments dérivés de cellules
CN107119120A (zh) *	2017-05-04	2017-09-01	河海大学常州校区	一种基于染色质3d构象技术的关键作用分子检测方法
CN111655848A (zh)	2017-11-21	2020-09-11	阿瑞玛基因组学公司	在核酸模板中保留空间邻位邻接性和分子邻接性
US12378592B2 (en)	2018-01-31	2025-08-05	Dovetail Genomics, Llc.	Sample prep for DNA linkage recovery
JP7502787B2 (ja)	2018-04-09	2024-06-19	ザボードオブトラスティーズオブザレランドスタンフォードジュニアユニバーシティー	インサイチュ遺伝子配列決定の方法
WO2020028194A1 (fr)	2018-07-30	2020-02-06	Readcoor, Inc.	Procédés et systèmes de traitement ou d'analyse d'échantillons
WO2020076976A1 (fr)	2018-10-10	2020-04-16	Readcoor, Inc.	Indexation moléculaire spatiale tridimensionnelle
US20220251640A1 (en) *	2019-05-17	2022-08-11	The Broad Institute, Inc.	Methods of determination of genome architecture and epigenetic profile
WO2021224233A1 (fr)	2020-05-04	2021-11-11	Cergentis B.V.	Procédé
GB202006546D0 (en)	2020-05-04	2020-06-17	Cergentis B V	Method
WO2021224225A1 (fr)	2020-05-04	2021-11-11	Cergentis B.V.	Procédé
GB202006550D0 (en)	2020-05-04	2020-06-17	Cergentis B V	Method
US20220049303A1 (en)	2020-08-17	2022-02-17	Readcoor, Llc	Methods and systems for spatial mapping of genetic variants
WO2022114957A1 (fr)	2020-11-26	2022-06-02	Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis	Marqueurs tumoraux personnalisés
EP4352254A4 (fr) *	2021-05-21	2025-04-16	The Board Of Trustees Of The Leland Stanford Junior University	Séquençage in situ volumétrique de prochaine génération
GB202111194D0 (en)	2021-08-03	2021-09-15	Cergentis B V	Method

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5077204A (en) *	1984-06-21	1991-12-31	Chiron Corporation	Yeast endopeptidase for basic amino-acid site cleavage, preparation and use
US9328391B1 (en) *	1984-08-22	2016-05-03	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Cloning and expression of HIV-1 DNA
JPS6226300A (ja) *	1984-10-10	1987-02-04	セントコ−・インコ−ポレ−テツド	Ｈｔｌｖ−３ｄｎａのクロ−ニングおよび発現
US5221518A (en) *	1984-12-14	1993-06-22	Mills Randell L	DNA sequencing apparatus
US5258507A (en) *	1990-11-08	1993-11-02	Amoco Corporation	Labeling reagents useful for the chemical attachment of nitrophenyl derivative ligands to DNA probes
US6060644A (en) *	1994-03-24	2000-05-09	Iowa State University Research Foundation, Inc.	Isolation and use of cuticular lipid genes
EP1736554B1 (fr) *	1996-05-29	2013-10-09	Cornell Research Foundation, Inc.	Detection de differences dans des sequences d'acides nucleiques utilisant une combinaison de la detection par ligase et de reactions d'amplification en chaine par polymerase
EP0960123A4 (fr) *	1996-11-07	2004-05-19	Univ Leland Stanford Junior	Proteine ramifiee et sequence codante
US6261804B1 (en) *	1997-01-21	2001-07-17	The General Hospital Corporation	Selection of proteins using RNA-protein fusions
ATE273381T1 (de) *	1997-02-12	2004-08-15	Eugene Y Chan	Verfahren zur analyse von polymeren
EP1044264A2 (fr) *	1997-12-02	2000-10-18	E.I. Du Pont De Nemours And Company	Enzymes biosynthetiques a acides amines ramifies
US6455692B1 (en) *	1998-08-04	2002-09-24	Transgenomic, Inc.	Method of concentrating polynucleotides using MIPC
US6291168B1 (en) *	1998-10-27	2001-09-18	Auburn University	Nucleic acid sequences diagnostic for pathogenic E.coli O157:H7, methods of identification and kit therefore
US20050232900A1 (en) *	1999-05-18	2005-10-20	Crucell Holland B.V.	Serotype of adenovirus and uses thereof
AU1824101A (en) *	1999-06-18	2001-01-09	Elitra Pharmaceuticals, Inc.	Nucleotide sequences of moraxella catarrhalis genome
US7470507B2 (en) *	1999-09-01	2008-12-30	Whitehead Institute For Biomedical Research	Genome-wide location and function of DNA binding proteins
US20040014195A1 (en) *	1999-12-29	2004-01-22	Diversa Corporation	Nitrilases, nucleic acids encoding them and methods for making and using them
EP1425579A2 (fr) *	2000-08-14	2004-06-09	TransGenetics Incorporated	Decouverte de gene cible de facteur de transcription
US6709861B2 (en) *	2000-11-17	2004-03-23	Lucigen Corp.	Cloning vectors and vector components
US20030054347A1 (en) *	2001-04-27	2003-03-20	The Regents Of The University Of Michigan	Latrophilin Polynucleotides
US20030013863A1 (en) *	2001-07-16	2003-01-16	Buchholz Wallace G.	High resolution DNA size standards
US20030157705A1 (en) *	2001-08-10	2003-08-21	Fodor William L.	Engineered recombinant molecule that regulates humoral and cellular effector functions of the immune system
AUPR823601A0 (en) *	2001-10-12	2001-11-08	University Of Queensland, The	Automated genotyping
AU2003237312A1 (en) *	2002-05-29	2003-12-19	University Of Washington	Mutants of gad65 and ian5 relating to diabetes
EP1923464A1 (fr) *	2002-08-30	2008-05-21	Japan Science and Technology Agency	Ligase de bactérie hyperthermostable et puce utilisant une telle ligase
ES2315397T3 (es) *	2002-09-30	2009-04-01	F. Hoffmann-La Roche Ag	Oligonucleotidos para obtener el genotipo del gen de timidilato sintasa.
US7575865B2 (en) *	2003-01-29	2009-08-18	454 Life Sciences Corporation	Methods of amplifying and sequencing nucleic acids
CA2517899A1 (fr) *	2003-03-06	2004-09-16	Children's Hospital, Inc.	Genes d'un isolat de l'otite moyenne de haemophilus influenzae non typable
FR2852317B1 (fr) *	2003-03-13	2006-08-04		Biopuces a sondes et leurs methodes d'utilisation
EP1670505B1 (fr) *	2003-09-18	2012-11-14	GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Promoteurs d'adn et vaccins contre l'anthrax
US20060150283A1 (en) *	2004-02-13	2006-07-06	Nickolai Alexandrov	Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
US20060107345A1 (en) *	2003-09-30	2006-05-18	Nickolai Alexandrov	Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
US20050221341A1 (en) *	2003-10-22	2005-10-06	Shimkets Richard A	Sequence-based karyotyping
WO2005047521A2 (fr) *	2003-11-10	2005-05-26	Investigen, Inc.	Procedes de preparation d'acides nucleiques en vue de leur detection
CN101072882A (zh) *	2004-09-10	2007-11-14	塞昆纳姆股份有限公司	用于核酸长程序列分析的方法
US20070048748A1 (en) *	2004-09-24	2007-03-01	Li-Cor, Inc.	Mutant polymerases for sequencing and genotyping
US20060223073A1 (en) *	2005-03-31	2006-10-05	Boyes Barry E	Methods of using a DNase I-like enzyme
US7601499B2 (en) *	2005-06-06	2009-10-13	454 Life Sciences Corporation	Paired end sequencing
US8407013B2 (en) *	2005-06-07	2013-03-26	Peter K. Rogan	AB initio generation of single copy genomic probes
EP3492602A1 (fr) *	2005-06-15	2019-06-05	Complete Genomics, Inc.	Réseaux de molécules simples pour l'analyse génétique et chimique
US20090142758A1 (en) *	2005-06-23	2009-06-04	Keygene N V	Strategies for sequencing complex genomes using high throughput sequencing technologies
CN105039313B (zh) *	2005-06-23	2018-10-23	科因股份有限公司	用于多态性的高通量鉴定和检测的策略
NZ564262A (en) *	2005-07-04	2010-02-26	Univ Erasmus Medical Ct	Chromosome conformation capture-on-chip (4C) assay
US20090143240A1 (en) *	2005-08-25	2009-06-04	Harbison Christopher T	Novel Methods for Genome-Wide Location Analysis
WO2007030678A2 (fr) *	2005-09-07	2007-03-15	Whitehead Institute For Biomedical Research	Procedes d'analyse de localisation sur tout le genome dans des cellules souches
US8071310B2 (en) *	2005-11-14	2011-12-06	Keygene Nv	Method for the high throughput screening of transposon tagging populations and massive parallel sequence identification of insertion sites
JP5285431B2 (ja) *	2005-12-28	2013-09-11	ザユーエイビーリサーチファウンデイション	肺炎球菌血清型
GB0603251D0 (en) *	2006-02-17	2006-03-29	Isis Innovation	DNA conformation
US20080015494A1 (en)	2006-07-11	2008-01-17	Microchips, Inc.	Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
US9328378B2 (en) *	2006-07-31	2016-05-03	Illumina Cambridge Limited	Method of library preparation avoiding the formation of adaptor dimers
DE112007002823T5 (de) *	2006-11-27	2009-09-10	Dsm Ip Assets B.V.	Fermentative Herstellung von Hydroxytyrosol
WO2008076406A2 (fr) *	2006-12-14	2008-06-26	Ion Torrent Systems Incorporated	Procédés et appareil permettant de mesurer des analytes en utilisant des matrices de tec à grande échelle
ES2634266T3 (es) *	2007-01-11	2017-09-27	Erasmus University Medical Center	Captura de conformación cromosómica circular (4C)
ATE521948T1 (de) *	2007-01-26	2011-09-15	Illumina Inc	System und verfahren zur nukleinsäuresequenzierung
US20100120036A1 (en) *	2007-03-07	2010-05-13	Kunio Shiota	Method for amplifying dna fragment
US20080248958A1 (en) *	2007-04-05	2008-10-09	Hollenbach Andrew D	System for pulling out regulatory elements in vitro
US7932030B2 (en) *	2007-04-05	2011-04-26	The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College	System for pulling out regulatory elements using yeast
CN101720359A (zh) *	2007-06-01	2010-06-02	454生命科学公司	从多重混合物中识别个别样本的系统和方法
EP2053132A1 (fr) *	2007-10-23	2009-04-29	Roche Diagnostics GmbH	Enrichissement et analyse de séquence de régions génomiques
US8518640B2 (en) *	2007-10-29	2013-08-27	Complete Genomics, Inc.	Nucleic acid sequencing and process
US8263367B2 (en) *	2008-01-25	2012-09-11	Agency For Science, Technology And Research	Nucleic acid interaction analysis
US8296075B2 (en) *	2008-05-21	2012-10-23	Mito Tech, LLC	Computer system and computer-facilitated method for nucleic acid sequence alignment and analysis
WO2009143499A1 (fr) *	2008-05-23	2009-11-26	Life Technologies Corporation	Procédés et kits pour l’extraction d’adn
FR2945545B1 (fr) *	2009-05-14	2011-08-05	Univ Aix Marseille Ii	Methode de detection d'adn procaryote extrait d'un echantillon de selles
US9493822B2 (en) *	2009-09-01	2016-11-15	Koninklijke Philips Electronics N.V.	Devices and methods for microarray selection
EP2354243A1 (fr)	2010-02-03	2011-08-10	Lexogen GmbH	Procédé de réduction de la complexité
JP5901046B2 (ja) *	2010-02-19	2016-04-06	国立大学法人千葉大学	ＯＡＴＰ１Ｂ３ｍＲＮＡの新規な選択的スプライシングバリアント
HRP20180593T1 (hr)	2010-07-09	2018-07-27	Cergentis B.V.	Strategije 3-d sekvenciranja genomskog područja od interesa
WO2018044831A1 (fr) *	2016-08-30	2018-03-08	Integrated Dna Technologies, Inc.	Amorces clivables en épingle à cheveux

2011
- 2011-07-08 HR HRP20180593TT patent/HRP20180593T1/hr unknown
- 2011-07-08 ES ES11736190.7T patent/ES2667346T3/es active Active
- 2011-07-08 RS RS20180488A patent/RS57295B1/sr unknown
- 2011-07-08 LT LTEP11736190.7T patent/LT2591125T/lt unknown
- 2011-07-08 PT PT181631235T patent/PT3360975T/pt unknown
- 2011-07-08 PL PL11736190T patent/PL2591125T3/pl unknown
- 2011-07-08 KR KR1020137003437A patent/KR101862756B1/ko active Active
- 2011-07-08 JP JP2013518301A patent/JP5977234B2/ja active Active
- 2011-07-08 ES ES18163123T patent/ES2916339T3/es active Active
- 2011-07-08 DK DK18163123.5T patent/DK3360975T3/da active
- 2011-07-08 CN CN201180034117.6A patent/CN103180459B/zh active Active
- 2011-07-08 HU HUE11736190A patent/HUE037359T2/hu unknown
- 2011-07-08 RU RU2013105459/10A patent/RU2603082C2/ru active
- 2011-07-08 PL PL18163123T patent/PL3360975T3/pl unknown
- 2011-07-08 US US13/807,662 patent/US12006538B2/en active Active
- 2011-07-08 SG SG2013001029A patent/SG186954A1/en unknown
- 2011-07-08 CA CA2804450A patent/CA2804450C/fr active Active
- 2011-07-08 EP EP11736190.7A patent/EP2591125B1/fr active Active
- 2011-07-08 WO PCT/NL2011/050504 patent/WO2012005595A2/fr not_active Ceased
- 2011-07-08 SM SM20180213T patent/SMT201800213T1/it unknown
- 2011-07-08 NO NO11736190A patent/NO2591125T3/no unknown
- 2011-07-08 NZ NZ606228A patent/NZ606228A/en unknown
- 2011-07-08 PT PT117361907T patent/PT2591125T/pt unknown
- 2011-07-08 EP EP22164776.1A patent/EP4063518A1/fr not_active Withdrawn
- 2011-07-08 BR BR112013000552A patent/BR112013000552B8/pt active IP Right Grant
- 2011-07-08 SI SI201131467T patent/SI2591125T1/en unknown
- 2011-07-08 EP EP18163123.5A patent/EP3360975B1/fr active Active
- 2011-07-08 AU AU2011274642A patent/AU2011274642B2/en active Active
- 2011-07-08 DK DK11736190.7T patent/DK2591125T3/en active
2013
- 2013-01-07 IL IL224127A patent/IL224127B/en active IP Right Grant
- 2013-01-15 ZA ZA2013/00375A patent/ZA201300375B/en unknown
2017
- 2017-12-24 IL IL256509A patent/IL256509B/en active IP Right Grant
2018
- 2018-05-03 CY CY20181100457T patent/CY1121702T1/el unknown
2024
- 2024-06-10 US US18/738,818 patent/US20250066846A1/en active Pending

Also Published As

Publication number	Publication date
US20130183672A1 (en)	2013-07-18
PL3360975T3 (pl)	2022-07-11
JP5977234B2 (ja)	2016-08-24
IL224127B (en)	2018-01-31
PT2591125T (pt)	2018-05-09
EP2591125A2 (fr)	2013-05-15
SMT201800213T1 (it)	2018-07-17
IL256509B (en)	2020-02-27
PL2591125T3 (pl)	2018-09-28
RU2013105459A (ru)	2014-08-20
SI2591125T1 (en)	2018-08-31
RS57295B1 (sr)	2018-08-31
RU2603082C2 (ru)	2016-11-20
CN103180459A (zh)	2013-06-26
WO2012005595A8 (fr)	2012-04-26
ES2916339T3 (es)	2022-06-30
KR101862756B1 (ko)	2018-05-30
IL256509A (en)	2018-02-28
ZA201300375B (en)	2014-03-26
EP2591125B1 (fr)	2018-04-04
NO2591125T3 (fr)	2018-09-01
CN103180459B (zh)	2016-10-19
SG186954A1 (en)	2013-02-28
US12006538B2 (en)	2024-06-11
CY1121702T1 (el)	2020-07-31
DK3360975T3 (da)	2022-04-11
WO2012005595A3 (fr)	2012-03-08
EP3360975A1 (fr)	2018-08-15
EP4063518A1 (fr)	2022-09-28
BR112013000552B1 (pt)	2021-03-02
CA2804450C (fr)	2022-10-11
KR20130049808A (ko)	2013-05-14
US20250066846A1 (en)	2025-02-27
AU2011274642B2 (en)	2015-05-21
JP2013530709A (ja)	2013-08-01
LT2591125T (lt)	2018-07-25
PT3360975T (pt)	2022-04-11
BR112013000552B8 (pt)	2023-01-17
WO2012005595A2 (fr)	2012-01-12
HUE037359T2 (hu)	2018-08-28
EP3360975B1 (fr)	2022-03-30
ES2667346T9 (es)	2018-06-11
NZ606228A (en)	2014-12-24
HRP20180593T1 (hr)	2018-07-27
AU2011274642A1 (en)	2013-02-21
CA2804450A1 (fr)	2012-01-12
BR112013000552A2 (pt)	2016-05-24
DK2591125T3 (en)	2018-05-14

Publication	Publication Date	Title
ES2667346T3 (es)	2018-05-10	Estrategias de secuenciación de región genómica 3-D de interés
ES2829295T3 (es)	2021-05-31	Detección de alto rendimiento de marcadores moleculares basados en AFLP y secuenciación de alto rendimiento
ES2688458T5 (es)	2022-04-13	Recuento varietal de ácidos nucleicos para obtener información del número de copias genómicas
ES2387878T3 (es)	2012-10-03	Estrategias para la identificación de alto rendimiento y la detección de polimorfismos
ES2962223T3 (es)	2024-03-18	Métodos para unir adaptadores a ácidos nucleicos de muestra
US20180251845A1 (en)	2018-09-06	Array-based translocation and rearrangement assays
ES2993028T3 (en)	2024-12-20	Methods and kits for amplification of double stranded dna
CN109477101A (zh)	2019-03-15	从保存的样品中回收长范围连锁信息
ES2776202T3 (es)	2020-07-29	Captura de conformación cromosómica dirigida
US20240352518A1 (en)	2024-10-24	Methods for simultaneous mutation detection and methylation analysis
US20160040228A1 (en)	2016-02-11	Sequencing strategies for genomic regions of interest
ES2971348T3 (es)	2024-06-04	Métodos de reparación de salientes 3'
HK1259754A1 (en)	2019-12-06	3-d genomic region of interest sequencing strategies
HK1259754B (en)	2022-07-15	3-d genomic region of interest sequencing strategies